Cargando…
Quantification of myocardial (99m)Tc-labeled bisphosphonate uptake with cadmium zinc telluride camera in patients with transthyretin-related cardiac amyloidosis
PURPOSE: We aimed to compare different methods for semi-quantitative analysis of cardiac retention of bone tracers in patients with cardiac transthyretin amyloidosis (ATTR). METHODS: Data from 67 patients with ATTR who underwent both conventional whole-body scan and a CZT myocardial SPECT (DSPECT, S...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928186/ https://www.ncbi.nlm.nih.gov/pubmed/31873816 http://dx.doi.org/10.1186/s13550-019-0584-8 |
_version_ | 1783482429533585408 |
---|---|
author | Manrique, Alain Dudoignon, David Brun, Stéphanie N’Ganoa, Catherine Cassol, Emmanuelle Legallois, Damien Lavie-Badie, Yoan Agostini, Denis Lairez, Olivier |
author_facet | Manrique, Alain Dudoignon, David Brun, Stéphanie N’Ganoa, Catherine Cassol, Emmanuelle Legallois, Damien Lavie-Badie, Yoan Agostini, Denis Lairez, Olivier |
author_sort | Manrique, Alain |
collection | PubMed |
description | PURPOSE: We aimed to compare different methods for semi-quantitative analysis of cardiac retention of bone tracers in patients with cardiac transthyretin amyloidosis (ATTR). METHODS: Data from 67 patients with ATTR who underwent both conventional whole-body scan and a CZT myocardial SPECT (DSPECT, Spectrum Dynamics) 3 h after injection of (99m)Tc-labeled bone tracer were analyzed. Visual scoring of cardiac retention was performed on whole-body scan according to Perugini 4-point grading system from 0 (no uptake) to 3 (strong cardiac uptake with mild/absent bone uptake). A planar heart-to-background (H:B) ratio was calculated using whole-body scan (wb-H:B). CZT SPECT was quantified using three methods: planar H:B ratio calculated from anterior reprojection (ant-H:B), left anterior oblique reprojection (LAO-H:B), and 3D-H:B ratio calculated from transaxial slices as mean counts in a VOI encompassing the heart divided by background VOI in the contralateral lung. Interventricular septal thickness was obtained using echocardiography. RESULTS: H:Bs obtained from planar and reprojected data were not statistically different (wb-H:B, 2.05 ± 0.64, ant-H:B, 1.97 ± 0.61, LAO-H:B, 2.06 ± 0.64, all p = ns). However, 3D-H:B was increased compared to planar H:Bs (3D-H:B, 4.06 ± 1.77, all p < 0.0001 vs. wb-H:B, ant-H:B, and LAO-H:B). Bland-Altman plots demonstrated that the difference between 3D and planar H:Bs increased with the mean value of myocardial uptake. 3D-H:B was best correlated to septal thickness (r = 0.45, p < 0.001). Finally, abnormal right ventricular uptake was associated with higher values of cardiac retention. CONCLUSION: 3D semi-quantitative analysis of CZT SPECT optimized the assessment of (99m)Tc-labeled bone tracer myocardial uptake in patients with cardiac amyloidosis. |
format | Online Article Text |
id | pubmed-6928186 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-69281862020-01-08 Quantification of myocardial (99m)Tc-labeled bisphosphonate uptake with cadmium zinc telluride camera in patients with transthyretin-related cardiac amyloidosis Manrique, Alain Dudoignon, David Brun, Stéphanie N’Ganoa, Catherine Cassol, Emmanuelle Legallois, Damien Lavie-Badie, Yoan Agostini, Denis Lairez, Olivier EJNMMI Res Original Research PURPOSE: We aimed to compare different methods for semi-quantitative analysis of cardiac retention of bone tracers in patients with cardiac transthyretin amyloidosis (ATTR). METHODS: Data from 67 patients with ATTR who underwent both conventional whole-body scan and a CZT myocardial SPECT (DSPECT, Spectrum Dynamics) 3 h after injection of (99m)Tc-labeled bone tracer were analyzed. Visual scoring of cardiac retention was performed on whole-body scan according to Perugini 4-point grading system from 0 (no uptake) to 3 (strong cardiac uptake with mild/absent bone uptake). A planar heart-to-background (H:B) ratio was calculated using whole-body scan (wb-H:B). CZT SPECT was quantified using three methods: planar H:B ratio calculated from anterior reprojection (ant-H:B), left anterior oblique reprojection (LAO-H:B), and 3D-H:B ratio calculated from transaxial slices as mean counts in a VOI encompassing the heart divided by background VOI in the contralateral lung. Interventricular septal thickness was obtained using echocardiography. RESULTS: H:Bs obtained from planar and reprojected data were not statistically different (wb-H:B, 2.05 ± 0.64, ant-H:B, 1.97 ± 0.61, LAO-H:B, 2.06 ± 0.64, all p = ns). However, 3D-H:B was increased compared to planar H:Bs (3D-H:B, 4.06 ± 1.77, all p < 0.0001 vs. wb-H:B, ant-H:B, and LAO-H:B). Bland-Altman plots demonstrated that the difference between 3D and planar H:Bs increased with the mean value of myocardial uptake. 3D-H:B was best correlated to septal thickness (r = 0.45, p < 0.001). Finally, abnormal right ventricular uptake was associated with higher values of cardiac retention. CONCLUSION: 3D semi-quantitative analysis of CZT SPECT optimized the assessment of (99m)Tc-labeled bone tracer myocardial uptake in patients with cardiac amyloidosis. Springer Berlin Heidelberg 2019-12-23 /pmc/articles/PMC6928186/ /pubmed/31873816 http://dx.doi.org/10.1186/s13550-019-0584-8 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Research Manrique, Alain Dudoignon, David Brun, Stéphanie N’Ganoa, Catherine Cassol, Emmanuelle Legallois, Damien Lavie-Badie, Yoan Agostini, Denis Lairez, Olivier Quantification of myocardial (99m)Tc-labeled bisphosphonate uptake with cadmium zinc telluride camera in patients with transthyretin-related cardiac amyloidosis |
title | Quantification of myocardial (99m)Tc-labeled bisphosphonate uptake with cadmium zinc telluride camera in patients with transthyretin-related cardiac amyloidosis |
title_full | Quantification of myocardial (99m)Tc-labeled bisphosphonate uptake with cadmium zinc telluride camera in patients with transthyretin-related cardiac amyloidosis |
title_fullStr | Quantification of myocardial (99m)Tc-labeled bisphosphonate uptake with cadmium zinc telluride camera in patients with transthyretin-related cardiac amyloidosis |
title_full_unstemmed | Quantification of myocardial (99m)Tc-labeled bisphosphonate uptake with cadmium zinc telluride camera in patients with transthyretin-related cardiac amyloidosis |
title_short | Quantification of myocardial (99m)Tc-labeled bisphosphonate uptake with cadmium zinc telluride camera in patients with transthyretin-related cardiac amyloidosis |
title_sort | quantification of myocardial (99m)tc-labeled bisphosphonate uptake with cadmium zinc telluride camera in patients with transthyretin-related cardiac amyloidosis |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928186/ https://www.ncbi.nlm.nih.gov/pubmed/31873816 http://dx.doi.org/10.1186/s13550-019-0584-8 |
work_keys_str_mv | AT manriquealain quantificationofmyocardial99mtclabeledbisphosphonateuptakewithcadmiumzinctelluridecamerainpatientswithtransthyretinrelatedcardiacamyloidosis AT dudoignondavid quantificationofmyocardial99mtclabeledbisphosphonateuptakewithcadmiumzinctelluridecamerainpatientswithtransthyretinrelatedcardiacamyloidosis AT brunstephanie quantificationofmyocardial99mtclabeledbisphosphonateuptakewithcadmiumzinctelluridecamerainpatientswithtransthyretinrelatedcardiacamyloidosis AT nganoacatherine quantificationofmyocardial99mtclabeledbisphosphonateuptakewithcadmiumzinctelluridecamerainpatientswithtransthyretinrelatedcardiacamyloidosis AT cassolemmanuelle quantificationofmyocardial99mtclabeledbisphosphonateuptakewithcadmiumzinctelluridecamerainpatientswithtransthyretinrelatedcardiacamyloidosis AT legalloisdamien quantificationofmyocardial99mtclabeledbisphosphonateuptakewithcadmiumzinctelluridecamerainpatientswithtransthyretinrelatedcardiacamyloidosis AT laviebadieyoan quantificationofmyocardial99mtclabeledbisphosphonateuptakewithcadmiumzinctelluridecamerainpatientswithtransthyretinrelatedcardiacamyloidosis AT agostinidenis quantificationofmyocardial99mtclabeledbisphosphonateuptakewithcadmiumzinctelluridecamerainpatientswithtransthyretinrelatedcardiacamyloidosis AT lairezolivier quantificationofmyocardial99mtclabeledbisphosphonateuptakewithcadmiumzinctelluridecamerainpatientswithtransthyretinrelatedcardiacamyloidosis |